GlassScriptPhysician profile
Selby Gage Rouch
NPI 1376005942
$3,670.79
in general payments reported to CMS, 2019-2025
16 companies · $1,056 in 2025
The $1,056 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $698 · 2022: $405 · 2023: $745 · 2024: $766 · 2025: $1,056.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,566.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,135.22 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $455.12 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Medtronic, INC. | $383.75 | 2021-2025 | Minimed 780g |
| Boehringer Ingelheim Pharmaceuticals, INC. | $318.92 | 2022-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $273.68 | 2021-2025 | |
| Insulet Corporation | $230.28 | 2021-2025 | Omnipod |
| Mannkind Corporation | $188.24 | 2022-2025 | Afrezza |
| Tandem Diabetes Care, INC. | $128.34 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $119.89 | 2023-2025 | Dexcom G6 Transmitter |
| Cequr Corporation | $96.89 | 2024-2025 | Cequr Simplicity |
| Xeris Pharmaceuticals, INC. | $90.92 | 2025 | Gvoke Hypopen |
| Abbott Laboratories | $69.63 | 2023-2025 | Freestyle Libre 3 |
| Beta Bionics, INC. | $55.02 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Sequel Med Tech, LLC | $53.02 | 2025 | Twiist |
| Astrazeneca Pharmaceuticals LP | $38.64 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amphastar Pharmaceuticals, INC. | $33.23 | 2023 | Baqsimi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Selby Rouch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.